China Launches First Human Trials For 'Nasal Spray' COVID-19 Vaccine
Antibody test developed for COVID-19 that is sensitive, specific and scalable
Savara's long-reigning duo both resign in the wake of CF bust
Covid-19 roundup: NIH spotlights blood thinners in its next big trial; All it took was a pandemic to get JPM out of SF
GSK and J&J alum Vijay Reddy to take control of R&D at Tmunity; Andrew Hirsch exits Agios for CEO job at C4 Therapeutics
What’s in your medicine may surprise you – a call for greater transparency about inactive ingredients
Futures Rebound In Shaky Markets With Stocks On Pace For 2nd Weekly Drop
Is Inovio Stock a Buy Right Now? This Is What You Need to Know
Study takes us a step closer to a universal antibody test for COVID-19
Pascal Soriot says 2020 approval still possible for AstraZeneca's Covid-19 vaccine as the world awaits the safety board's decision
Moderna Stock Could Tumble Over 20%, Says Analyst
Billionaire David Shaw Pours Money Into 3 "Strong Buy" Stocks
Kamada Rises 5% On Initial Phase 1/2 Trial Results For Covid Treatment
Futures Rebound, Oil Jumps After Relentless 3-Day Hammering
COVID19 vaccine makers’ pledge no better than NRA’s promises
Spain First In Western Europe To Top 500k COVID-19 Cases As "Second Wave" Intensifies: Live Updates
Trump will not interfere with vaccine approval process, FDA chief reassures staff
How the government can drive medical innovation amidst the pandemic
Unpleasant truth: the pandemic, record debt and our opportunity for sustainability
Dr Reddy's Launches Generic Version Of AstraZeneca's Faslodex In US
"The Correction Has Further Room To Go": Futures Recover Early Losses As European Markets Jump
Switzerland’s ender to provide rapid COVID-19 diagnostics tests for cabin crew
Gilead Submits Expanded Application For Yescarta Cancer Treatment
Eli Lilly Gets FDA Nod For Additional Doses Of Trulicity
Trump Vaccine Czar Says COVID-19 Vaccine By Election Day "Very, Very Unlikely"
What Pac-12’s New Rapid COVID-19 Tests Mean for Sports Return
AMA Joins Law Suit Targeting “Menthol Slavery”
Vertex and Covid-19 spell the end for Savara's CF program
Is Trevena Stock a Buy Right Now? This Is What You Need to Know
Compass plans $100m IPO to fund magic mushroom depression drug